Abstract
BACKGROUND Although the chemical components of basal, reflex, and emotional tears are different, the presence of distinctions in the tears of different emotions is still unknown. The present study aimed to address the biochemical basis behind emotional tears through non-targeted metabolomics analysis between positive and negative emotional tears of humans.
METHODS Samples of reflex (C), negative (S), and positive (M) emotional tears were collected from healthy college participants. Untargeted metabolomics was performed to identify the metabolites in the different types of tears. The differentially altered metabolites were screened and assessed using univariate and multivariate analyses.
RESULTS The global metabolomics signatures classified the C, S, and M emotional tears. A total of 133 significantly differential metabolites of ESI-mode were identified between negative and positive emotional tears. The top 50 differential metabolites between S and M were highly correlated. The significantly altered pathways included porphyrin & chlorophyll metabolism, bile secretion, biotin metabolism, arginine & proline metabolism and among others.
CONCLUSION The metabolic profiles between reflex, positive, and negative emotional tears of humans are distinct. Secretion of positive and negative emotional tears are distinctive biological activities. Therefore, the present study provides a chemical method to detect human emotions which may become a powerful tool for diagnosis of mental disease and identification of fake tears.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
ChiCTR2100047025
Funding Statement
the grants of China Postdoctoral Science Foundation (No. 2020M682578), Science and Technology Innovation Program of Hunan Province (No.2020RC2061), Guidance Project of Liu Liang Academician Workstation (21YS002), and Key Projects of TCM Scientific Research Program in Hunan Province (No.201901).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The protocol of the current study was approved by the ethics committee of Jili Hospital and was conducted in accordance with the Decoration of Helsinki.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Raw and processed datasets of mass spectrum generated during and/or analyzed during the current study are available in the China National GeneBank DataBase (CNGBdb) Repository, https://db.cngb.org/search/metabolize/METM0000028/. Furthermore, the datasets of all the identified metabolites information can be downloaded from https://github.com/hao203/tears
